List of Tables
Table 1. Platinum-based Anticancer Drugs Market Trends
Table 2. Platinum-based Anticancer Drugs Market Drivers & Opportunity
Table 3. Platinum-based Anticancer Drugs Market Challenges
Table 4. Platinum-based Anticancer Drugs Market Restraints
Table 5. Global Platinum-based Anticancer Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Platinum-based Anticancer Drugs Sales Volume by Company (2019-2024) & (MT)
Table 8. Global Platinum-based Anticancer Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Platinum-based Anticancer Drugs Price by Company (2019-2024) & (US$/MT)
Table 10. Key Manufacturers Platinum-based Anticancer Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Platinum-based Anticancer Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Platinum-based Anticancer Drugs
Table 13. Global Platinum-based Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platinum-based Anticancer Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Platinum-based Anticancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Platinum-based Anticancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Platinum-based Anticancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Platinum-based Anticancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (MT)
Table 22. Global Platinum-based Anticancer Drugs Sales Volume by Type (2019-2024) & (MT)
Table 23. Global Platinum-based Anticancer Drugs Sales Volume by Type (2025-2030) & (MT)
Table 24. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Platinum-based Anticancer Drugs Price by Type (2019-2024) & (US$/MT)
Table 27. Global Platinum-based Anticancer Drugs Price by Type (2025-2030) & (US$/MT)
Table 28. Global Platinum-based Anticancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Platinum-based Anticancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Platinum-based Anticancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Platinum-based Anticancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Platinum-based Anticancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (MT)
Table 34. Global Platinum-based Anticancer Drugs Sales Volume by Application (2019-2024) & (MT)
Table 35. Global Platinum-based Anticancer Drugs Sales Volume by Application (2025-2030) & (MT)
Table 36. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Platinum-based Anticancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Platinum-based Anticancer Drugs Price by Application (2019-2024) & (US$/MT)
Table 39. Global Platinum-based Anticancer Drugs Price by Application (2025-2030) & (US$/MT)
Table 40. Global Platinum-based Anticancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Platinum-based Anticancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Platinum-based Anticancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Platinum-based Anticancer Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Platinum-based Anticancer Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Platinum-based Anticancer Drugs Sales Volume by Region (MT): 2019 VS 2023 VS 2030
Table 46. Global Platinum-based Anticancer Drugs Sales Volume by Region (2019-2024) & (MT)
Table 47. Global Platinum-based Anticancer Drugs Sales Volume by Region (2025-2030) & (MT)
Table 48. Global Platinum-based Anticancer Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Platinum-based Anticancer Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Platinum-based Anticancer Drugs Average Price by Region (2019-2024) & (US$/MT)
Table 51. Global Platinum-based Anticancer Drugs Average Price by Region (2025-2030) & (US$/MT)
Table 52. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Platinum-based Anticancer Drugs Sales Volume, (2019-2024) & (MT)
Table 56. Key Countries/Regions Platinum-based Anticancer Drugs Sales Volume, (2025-2030) & (MT)
Table 57. Sanofi-Aventis Company Information
Table 58. Sanofi-Aventis Introduction and Business Overview
Table 59. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 60. Sanofi-Aventis Platinum-based Anticancer Drugs Product Offerings
Table 61. Sanofi-Aventis Recent Development
Table 62. Yakult honsha Company Information
Table 63. Yakult honsha Introduction and Business Overview
Table 64. Yakult honsha Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 65. Yakult honsha Platinum-based Anticancer Drugs Product Offerings
Table 66. Yakult honsha Recent Development
Table 67. Dr Reddy's laboratories Company Information
Table 68. Dr Reddy's laboratories Introduction and Business Overview
Table 69. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 70. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offerings
Table 71. Dr Reddy's laboratories Recent Development
Table 72. Sun Pharmaceutical Company Information
Table 73. Sun Pharmaceutical Introduction and Business Overview
Table 74. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 75. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 76. Sun Pharmaceutical Recent Development
Table 77. Teva Company Information
Table 78. Teva Introduction and Business Overview
Table 79. Teva Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 80. Teva Platinum-based Anticancer Drugs Product Offerings
Table 81. Teva Recent Development
Table 82. Fresenius Kabi Company Information
Table 83. Fresenius Kabi Introduction and Business Overview
Table 84. Fresenius Kabi Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 85. Fresenius Kabi Platinum-based Anticancer Drugs Product Offerings
Table 86. Fresenius Kabi Recent Development
Table 87. Hospira(Pfizer) Company Information
Table 88. Hospira(Pfizer) Introduction and Business Overview
Table 89. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 90. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offerings
Table 91. Hospira(Pfizer) Recent Development
Table 92. Mylan Company Information
Table 93. Mylan Introduction and Business Overview
Table 94. Mylan Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 95. Mylan Platinum-based Anticancer Drugs Product Offerings
Table 96. Mylan Recent Development
Table 97. Taj Pharmaceuticals Company Information
Table 98. Taj Pharmaceuticals Introduction and Business Overview
Table 99. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 100. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offerings
Table 101. Taj Pharmaceuticals Recent Development
Table 102. Jiangsu Hengrui Medicine Company Information
Table 103. Jiangsu Hengrui Medicine Introduction and Business Overview
Table 104. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 105. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offerings
Table 106. Jiangsu Hengrui Medicine Recent Development
Table 107. Nanjing Pharmaceutical Factory Company Information
Table 108. Nanjing Pharmaceutical Factory Introduction and Business Overview
Table 109. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 110. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offerings
Table 111. Nanjing Pharmaceutical Factory Recent Development
Table 112. Jiangsu Aosaikang Pharmaceutical Company Information
Table 113. Jiangsu Aosaikang Pharmaceutical Introduction and Business Overview
Table 114. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 115. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 116. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 117. Qilu Pharmaceutical Company Information
Table 118. Qilu Pharmaceutical Introduction and Business Overview
Table 119. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 120. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 121. Qilu Pharmaceutical Recent Development
Table 122. Hisun Pharmaceutical Company Information
Table 123. Hisun Pharmaceutical Introduction and Business Overview
Table 124. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 125. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offerings
Table 126. Hisun Pharmaceutical Recent Development
Table 127. Luoxin Company Information
Table 128. Luoxin Introduction and Business Overview
Table 129. Luoxin Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 130. Luoxin Platinum-based Anticancer Drugs Product Offerings
Table 131. Luoxin Recent Development
Table 132. Lingnan Pharmacy Company Information
Table 133. Lingnan Pharmacy Introduction and Business Overview
Table 134. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 135. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offerings
Table 136. Lingnan Pharmacy Recent Development
Table 137. Hansoh Pharma Company Information
Table 138. Hansoh Pharma Introduction and Business Overview
Table 139. Hansoh Pharma Platinum-based Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
Table 140. Hansoh Pharma Platinum-based Anticancer Drugs Product Offerings
Table 141. Hansoh Pharma Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Platinum-based Anticancer Drugs Downstream Customers
Table 145. Platinum-based Anticancer Drugs Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Platinum-based Anticancer Drugs Product Picture
Figure 2. Global Platinum-based Anticancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Platinum-based Anticancer Drugs Sales Volume (2019-2030) & (MT)
Figure 5. Global Platinum-based Anticancer Drugs Sales Price (2019-2030) & (US$/MT)
Figure 6. Platinum-based Anticancer Drugs Report Years Considered
Figure 7. Global Platinum-based Anticancer Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Platinum-based Anticancer Drugs Players Sales Volume Ranking (2023) & (MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Platinum-based Anticancer Drugs Revenue in 2023
Figure 10. Platinum-based Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Cisplatin Picture
Figure 12. Carboplatin Picture
Figure 13. Oxaliplatin Picture
Figure 14. Nedaplatin Picture
Figure 15. Others Picture
Figure 16. Global Platinum-based Anticancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Platinum-based Anticancer Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Platinum-based Anticancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (MT)
Figure 19. Global Platinum-based Anticancer Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Platinum-based Anticancer Drugs Price by Type (2019-2030) & (US$/MT)
Figure 21. Product Picture of Testicular Cancer
Figure 22. Product Picture of Osteosarcoma
Figure 23. Product Picture of Breast Cancer
Figure 24. Product Picture of Esophageal Cancer
Figure 25. Product Picture of NSCLC
Figure 26. Product Picture of Other
Figure 27. Global Platinum-based Anticancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Platinum-based Anticancer Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 29. Global Platinum-based Anticancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (MT)
Figure 30. Global Platinum-based Anticancer Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 31. Global Platinum-based Anticancer Drugs Price by Application (2019-2030) & (US$/MT)
Figure 32. North America Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Europe Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Asia Pacific Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 38. South America Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 39. South America Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Platinum-based Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Platinum-based Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
Figure 42. Key Countries/Regions Platinum-based Anticancer Drugs Sales Value (%), (2019-2030)
Figure 43. Key Countries/Regions Platinum-based Anticancer Drugs Sales Volume (%), (2019-2030)
Figure 44. United States Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. United States Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. United States Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. Europe Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. Europe Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. Europe Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. China Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. China Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. China Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. Japan Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. Japan Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. Japan Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. South Korea Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 57. South Korea Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 58. South Korea Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 59. Southeast Asia Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 60. Southeast Asia Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 61. Southeast Asia Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 62. India Platinum-based Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 63. India Platinum-based Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
Figure 64. India Platinum-based Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
Figure 65. Platinum-based Anticancer Drugs Industrial Chain
Figure 66. Platinum-based Anticancer Drugs Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
